Caren Deardorf Magenta Therapeutics, Inc. (MGTA) insider trading activity

MGTA Quotes by TradingView

Caren Deardorf is Chief Commercial Officer of Magenta Therapeutics, Inc.. Currently has a direct ownership of 19,762 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2022, when has been sold 3,000 shares (Common Stock) at a price of $0.94 per share, resulting in proceeds of $2,820. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.8K
0% 3M change
0% 12M change
Total Value Held $0

Caren Deardorf Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2022
BUY
Grant, award, or other acquisition
$2,820 $0.94 p/Share
3,000 Added 13.18%
19,762 Common Stock
May 31 2022
BUY
Grant, award, or other acquisition
$2,970 $0.99 p/Share
3,000 Added 15.18%
16,762 Common Stock
Sep 16 2021
SELL
Open market or private sale
$41,982 $6.73 p/Share
6,238 Reduced 31.19%
13,762 Common Stock
Sep 14 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock

Also insider at

CRNX
Crinetics Pharmaceuticals, Inc. Healthcare
CD

Caren Deardorf

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MGTA